HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
Active Not RecruitingNCT06446765

Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder

This study is active but not recruiting. It focuses on personality disorders and currently lists study information in the United States.

Personality disorders, Borderline personalityBehavioralFrom 18 Years to 60 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether mindfulness training may be useful for adults experiencing personality disorders.

What would participation involve?

Participants may take part in mindfulness training, attend study visits with the research team. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with personality disorders.

What should you check before joining?

Ask about how many sessions are required and who delivers them, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: March 13, 2025
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
46
Sponsor
Yale University
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, OTHER
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT06446765
Official title
Mindfulness-based Neurofeedback to Augment Dialectical Behavior Therapy (DBT) for Adults With Borderline Personality Disorder (Aim 1)

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT06446765. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Not recruiting

New Haven

Checked Official study record (opens in a new tab)
Registry details
Registry conditions (original wording)

Borderline Personality Disorder

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Who can participate?

Listed age limits: 18 years to 60 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.

Behavioral study icon
Active Not RecruitingNCT07223619

Phase: BPD Study

This study is active but not recruiting. It focuses on personality disorders and currently lists study information in the United States.

Behavioral study icon
Active Not RecruitingNCT06176638

Resettled Refugee Families for Healing

This study is active but not recruiting. It focuses on personality disorders and currently lists study information in the United States.